Rhapsido 00078-1483-92
Generic: Remibrutinib
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 30, 2025
- Listing Expires
- December 31, 2027
- Application
- NDA218436
Need to source Rhapsido? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Remibrutinib | 25 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Bruton's Tyrosine Kinase Inhibitors [MoA]Kinase Inhibitor [EPC]
Selected Package
00078-1483-92Selected2 BOTTLE in 1 CARTON (0078-1483-92) / 30 TABLET in 1 BOTTLE
Other packages for this product(2)
60 TABLET in 1 BOTTLE (0078-1483-20)
30 TABLET in 1 BOTTLE (0078-1483-93)